TRNAIni CAT inhibits proliferation and promotes apoptosis of laryngeal squamous cell carcinoma cells.

Abstract

BackgroundLaryngeal squamous cell carcinoma (LSCC) brings a heavy blow to the patient's voice. Transfer RNA (tRNA) is a common RNA, the roles of tRNAs in LSCC are largely unknown.MethodsThe tRNA expression profile in LSCC tissues and adjacent normal tissues was measured by a tRNA qRT‐PCR array. The expression level of tRNAIni CAT in LSCC tissues and plasmas was detected by qRT‐PCR. The receiver operating characteristic (ROC) curve was established. tRNAIni CAT was upregulated by a lentivirus vector in the LSCC cell line. Moreover, tRNAIni CAT was upregulated in LSCC xenograft nude mouse model and the xenografts were used for pathological analysis and transmission electron microscope (TEM) observation.ResultsThe top 10 upregulated tRNAs were tRNALys CTT‐1, tRNALeu TAA, tRNAPhe GAA, tRNALeu CAG, tRNATyr ATA, tRNAMet CAT, tRNATyr GTA‐1, tRNAThr CGT, tRNATyr GTA‐2, tRNAAla AGC; and the top 10 downregulated tRNAs were tRNAIni CAT, mt‐tRNAGlu TTC, tRNAVal CAC‐3, mt‐tRNATrp TCA, mt‐tRNATyr GTA, mt‐tRNALys TTT, mt‐tRNAThr TGT, mt‐tRNAAsp GTC, mt‐tRNAAsn GTT, mt‐tRNAPro TGG. tRNAIni CAT was downregulated in LSCC tissues and plasma. The area under the ROC curve (AUC) in LSCC tissues and the plasma of patients with LSCC was 0.717 and 0.808, respectively. tRNAIni CAT inhibited LSCC cell proliferation and promoted apoptosis. The in vivo results showed that tRNAIni CAT inhibited the growth of the xenografts and promoted apoptosis.ConclusionsThis is the first study to provide tRNA expression profiles for LSCC tissues. tRNAIni CAT may be used as a new biomarker for the early diagnosis of LSCC. tRNAIni CAT inhibits cell proliferation and promotes apoptosis in vitro and in vivo.